2.0
13 May 2022
Former employee, more than 1 year
Chennai
Recommend
CEO approval
Business outlook
Pros
Salarywise and company ethics wise so good
Cons
In pharma division in India products for regulatory markets is very less even you can say 2 products and on which we need to play on sales figures. Although India major market, Brenntag India pharma division is very much neglected to core. No growth and very high sales pressure.